Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Blinded, No-Treatment Control, Multicenter, Prospective Clinical Study of TEOSYAL RHA® Redensity for the Treatment of Moderate to Severe Dynamic Perioral Rhytids

NCT03092219 is registered in ClinicalTrials.gov with Teoxane SA as lead sponsor.

NCT NCT03092219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03092219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Blinded, No-Treatment Control, Multicenter, Prospective Clinical Study of TEOSYAL RHA® Redensity for the Treatment of Moderate to Severe Dynamic Perioral Rhytids
Lead sponsor
Teoxane SA
Phase
Not applicable
Overall status
Completed
Start date
December 20, 2016
Completion date
January 8, 2019
Enrollment
202 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

aging, perioral rhytids, wrinkle